Genetic and epigenetic defects in mental retardation.

[1]  Andrew L Kung,et al.  Monoallele deletion of CBP leads to pericentromeric heterochromatin condensation through ESET expression and histone H3 (K9) methylation. , 2008, Human molecular genetics.

[2]  M. Grant.  The epigenetic origins of mental retardation , 2008, Clinical genetics.

[3]  David Crews,et al.  Epigenetics and its implications for behavioral neuroendocrinology , 2008, Frontiers in Neuroendocrinology.

[4]  Stephen T. C. Wong,et al.  MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription , 2008, Science.

[5]  Daniela C. Zarnescu,et al.  Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. , 2008, Nature chemical biology.

[6]  Qian Tao,et al.  DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. , 2008, Human molecular genetics.

[7]  R. Kuick,et al.  ICF, An Immunodeficiency Syndrome: DNA Methyltransferase 3B Involvement, Chromosome Anomalies, and Gene Dysregulation , 2008, Autoimmunity.

[8]  John N. Hutchinson,et al.  Widespread Monoallelic Expression on Human Autosomes , 2007, Science.

[9]  T. Kleefstra,et al.  The chromosome 9q subtelomere deletion syndrome , 2007, American journal of medical genetics. Part C, Seminars in medical genetics.

[10]  Huda Y. Zoghbi,et al.  The Story of Rett Syndrome: From Clinic to Neurobiology , 2007, Neuron.

[11]  Joost Gribnau,et al.  X inactivation Xplained. , 2007, Current opinion in genetics & development.

[12]  C. Allis,et al.  DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA , 2007, Nature.

[13]  P. Georgel,et al.  CHD proteins: a diverse family with strong ties. , 2007, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[14]  Y. Shinkai,et al.  Identification of ZNF200 as a novel binding partner of histone H3 methyltransferase G9a , 2007, Genes to cells : devoted to molecular & cellular mechanisms.

[15]  Allen D. Delaney,et al.  Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing , 2007, Nature Methods.

[16]  Joel M Stein,et al.  Histone Deacetylase Inhibitors Enhance Memory and Synaptic Plasticity via CREB: CBP-Dependent Transcriptional Activation , 2007, The Journal of Neuroscience.

[17]  A. Rao,et al.  The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation , 2007, Nature.

[18]  C. Sánchez,et al.  Proteomics Analysis of Ring1B/Rnf2 Interactors Identifies a Novel Complex with the Fbxl10/Jhdm1B Histone Demethylase and the Bcl6 Interacting Corepressor*S , 2007, Molecular & Cellular Proteomics.

[19]  Henriette O'Geen,et al.  Genome-Wide Analysis of KAP1 Binding Suggests Autoregulation of KRAB-ZNFs , 2007, PLoS genetics.

[20]  A. Verloes,et al.  PRACTICAL GENETICS In association with CHARGE syndrome : an update , 2007 .

[21]  Maite Huarte,et al.  The X-Linked Mental Retardation Gene SMCX/JARID1C Defines a Family of Histone H3 Lysine 4 Demethylases , 2007, Cell.

[22]  J. LaSalle,et al.  15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders. , 2007, Human molecular genetics.

[23]  A. Bird,et al.  Reversal of Neurological Defects in a Mouse Model of Rett Syndrome , 2007, Science.

[24]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[25]  A. Bird,et al.  Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation , 2007, Proceedings of the National Academy of Sciences.

[26]  Karl Mechtler,et al.  Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. , 2007, Molecular cell.

[27]  R. Jaenisch,et al.  Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2 , 2007, Proceedings of the National Academy of Sciences.

[28]  Vincenzo Pirrotta,et al.  Polycomb silencing mechanisms and the management of genomic programmes , 2007, Nature Reviews Genetics.

[29]  E. Weeber,et al.  Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of αCaMKII inhibitory phosphorylation , 2007, Nature Neuroscience.

[30]  Ben Abbas,et al.  Human heterochromatin proteins form large domains containing KRAB-ZNF genes. , 2006, Genome research.

[31]  Christina Thaller,et al.  Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome , 2006, Proceedings of the National Academy of Sciences.

[32]  Eric C. Griffith,et al.  Brain-Specific Phosphorylation of MeCP2 Regulates Activity-Dependent Bdnf Transcription, Dendritic Growth, and Spine Maturation , 2006, Neuron.

[33]  P. Marynen,et al.  X-linked mental retardation and epigenetics , 2006, Journal of cellular and molecular medicine.

[34]  D. C. Schultz,et al.  The KAP1 Corepressor Functions To Coordinate the Assembly of De Novo HP1-Demarcated Microenvironments of Heterochromatin Required for KRAB Zinc Finger Protein-Mediated Transcriptional Repression , 2006, Molecular and Cellular Biology.

[35]  J. A. Wamstad,et al.  Polycomb Group and SCF Ubiquitin Ligases Are Found in a Novel BCOR Complex That Is Recruited to BCL6 Targets , 2006, Molecular and Cellular Biology.

[36]  Alex Magee,et al.  Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. , 2006, American journal of human genetics.

[37]  M. Mitchell,et al.  PML nuclear bodies are highly organised DNA-protein structures with a function in heterochromatin remodelling at the G2 phase , 2006, Journal of Cell Science.

[38]  Jamel Chelly,et al.  Genetics and pathophysiology of mental retardation , 2006, European Journal of Human Genetics.

[39]  R. Gibbons.  Alpha thalassaemia-mental retardation, X linked , 2006, Orphanet journal of rare diseases.

[40]  A. Riggs,et al.  Mutations in DNA methyltransferase DNMT3B in ICF syndrome affect its regulation by DNMT3L. , 2006, Human molecular genetics.

[41]  D. Higgs,et al.  Loss of Atrx Affects Trophoblast Development and the Pattern of X-Inactivation in Extraembryonic Tissues , 2006, PLoS genetics.

[42]  E. Li,et al.  Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome , 2006, Development.

[43]  M. Fraga,et al.  The Polycomb group protein EZH2 directly controls DNA methylation , 2006, Nature.

[44]  Sander B Nabuurs,et al.  ZNF674: a new kruppel-associated box-containing zinc-finger gene involved in nonsyndromic X-linked mental retardation. , 2006, American journal of human genetics.

[45]  M. Tranfaglia,et al.  Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP , 2005, Neuropharmacology.

[46]  G. Mandel,et al.  The many faces of REST oversee epigenetic programming of neuronal genes , 2005, Current Opinion in Neurobiology.

[47]  C. Schwartz,et al.  Mutations in PHF8 are associated with X linked mental retardation and cleft lip/cleft palate , 2005, Journal of Medical Genetics.

[48]  J. Gécz,et al.  Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. , 2005, American journal of human genetics.

[49]  E. Nestler,et al.  The many faces of CREB , 2005, Trends in Neurosciences.

[50]  A. Bird,et al.  Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. , 2005, Human molecular genetics.

[51]  N. Landsberger,et al.  CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. , 2005, Human molecular genetics.

[52]  G. Garcia-Manero,et al.  Future directions for the use of hypomethylating agents. , 2005, Seminars in hematology.

[53]  T. Kleefstra,et al.  X‐linked mental retardation: further lumping, splitting and emerging phenotypes , 2005, Clinical genetics.

[54]  G. Mandel,et al.  REST and Its Corepressors Mediate Plasticity of Neuronal Gene Chromatin throughout Neurogenesis , 2005, Cell.

[55]  Tsutomu Ohta,et al.  Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. , 2005, Genes & development.

[56]  Johan T den Dunnen,et al.  Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. , 2005, American journal of human genetics.

[57]  B. D. de Vries,et al.  Disruption of the gene Euchromatin Histone Methyl Transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome , 2005, Journal of Medical Genetics.

[58]  Yan Wang,et al.  Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome , 2005, Neuron.

[59]  M. Durán,et al.  Guanidinoacetate methyltransferase deficiency identified in adults and a child with mental retardation , 2005, American journal of medical genetics. Part A.

[60]  Rodney C Samaco,et al.  Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. , 2005, Human molecular genetics.

[61]  A. El-Osta,et al.  Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing , 2005, Nature Genetics.

[62]  J. Gécz,et al.  Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. , 2005, American journal of human genetics.

[63]  A. Young,et al.  A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Jan-Fang Cheng,et al.  Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome , 2005, Nature Genetics.

[65]  A. Mégarbané,et al.  Subcellular distribution of HP1 proteins is altered in ICF syndrome , 2005, European Journal of Human Genetics.

[66]  H. Ropers,et al.  X-linked mental retardation , 2005, Nature Reviews Genetics.

[67]  J. Gécz,et al.  Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. , 2004, American journal of human genetics.

[68]  J. Gécz,et al.  Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. , 2004, American journal of human genetics.

[69]  H. Zoghbi,et al.  Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. , 2004, Human molecular genetics.

[70]  E. Kalkhoven,et al.  CBP and p300: HATs for different occasions. , 2004, Biochemical pharmacology.

[71]  M. Walsh,et al.  CCAAT displacement protein/cut homolog recruits G9a histone lysine methyltransferase to repress transcription. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[72]  Gangning Liang,et al.  Preferential response of cancer cells to zebularine. , 2004, Cancer cell.

[73]  M. Mayford,et al.  CBP Histone Acetyltransferase Activity Is a Critical Component of Memory Consolidation , 2004, Neuron.

[74]  E. Kandel,et al.  Chromatin Acetylation, Memory, and LTP Are Impaired in CBP+/− Mice A Model for the Cognitive Deficit in Rubinstein-Taybi Syndrome and Its Amelioration , 2004, Neuron.

[75]  A. Roopra,et al.  Localized domains of G9a-mediated histone methylation are required for silencing of neuronal genes. , 2004, Molecular cell.

[76]  K. Robertson,et al.  DNMT3B interacts with hSNF2H chromatin remodeling enzyme, HDACs 1 and 2, and components of the histone methylation system. , 2004, Biochemical and biophysical research communications.

[77]  J. Mulley,et al.  The de novo chromosome 16 translocations of two patients with abnormal phenotypes (mental retardation and epilepsy) disrupt the A2BP1 gene , 2004, Journal of Human Genetics.

[78]  Keith D Robertson,et al.  Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery. , 2004, Nucleic acids research.

[79]  H. Ropers,et al.  Zinc finger 81 (ZNF81) mutations associated with X-linked mental retardation , 2004, Journal of Medical Genetics.

[80]  L. Biesecker,et al.  Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR , 2004, Nature Genetics.

[81]  Kazunari Taira,et al.  A Small Modulatory dsRNA Specifies the Fate of Adult Neural Stem Cells , 2004, Cell.

[82]  Jennifer K Inlow,et al.  Molecular and comparative genetics of mental retardation. , 2004, Genetics.

[83]  H. Ropers,et al.  Mutations in the ZNF41 gene are associated with cognitive deficits: identification of a new candidate for X-linked mental retardation. , 2003, American journal of human genetics.

[84]  Eric C. Griffith,et al.  Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2 , 2003, Science.

[85]  Daisuke Hattori,et al.  DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation , 2003, Science.

[86]  Ruth Luthi-Carter,et al.  Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice , 2003, The Journal of Neuroscience.

[87]  J. Qin,et al.  The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[88]  Pierre Chambon,et al.  NSD1 is essential for early post‐implantation development and has a catalytically active SET domain , 2003, The EMBO journal.

[89]  R. Srinivasan,et al.  The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor , 2003, Oncogene.

[90]  Yang Shi,et al.  Coordinated histone modifications mediated by a CtBP co-repressor complex , 2003, Nature.

[91]  N. Niikawa,et al.  Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a. , 2003, Human molecular genetics.

[92]  K. Shiota,et al.  Methyl-CpG-binding Protein, MeCP2, Is a Target Molecule for Maintenance DNA Methyltransferase, Dnmt1* , 2003, The Journal of Biological Chemistry.

[93]  Leslie M Thompson,et al.  Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[94]  P. Marynen,et al.  X‐linked mental retardation: vanishing boundaries between non‐specific (MRX) and syndromic (MRXS) forms , 2002, Clinical genetics.

[95]  M. Shaw,et al.  Mutations in PHF6 are associated with Börjeson–Forssman–Lehmann syndrome , 2002, Nature Genetics.

[96]  Dimitris Thanos,et al.  Integration of Long-Term-Memory-Related Synaptic Plasticity Involves Bidirectional Regulation of Gene Expression and Chromatin Structure , 2002, Cell.

[97]  R. Jaenisch,et al.  Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[98]  A. Hanauer,et al.  Coffin-Lowry syndrome: clinical and molecular features , 2002, Journal of medical genetics.

[99]  R. Roberts,et al.  Co‐operation and communication between the human maintenance and de novo DNA (cytosine‐5) methyltransferases , 2002, The EMBO journal.

[100]  H. Kato,et al.  G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. , 2002, Genes & development.

[101]  Shi Huang.  Histone methyltransferases, diet nutrients and tumour suppressors , 2002, Nature Reviews Cancer.

[102]  David M. Livingston,et al.  A Complex with Chromatin Modifiers That Occupies E2F- and Myc-Responsive Genes in G0 Cells , 2002, Science.

[103]  G. Maul,et al.  SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. , 2002, Genes & development.

[104]  D. Housman,et al.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila , 2001, Nature.

[105]  A. Harel-Bellan,et al.  Mitogen-Regulated RSK2-CBP Interaction Controls Their Kinase and Acetylase Activities , 2001, Molecular and Cellular Biology.

[106]  S. Ishii,et al.  The Ski Protein Family Is Required for MeCP2-mediated Transcriptional Repression* , 2001, The Journal of Biological Chemistry.

[107]  J. C. Eissenberg.  Molecular biology of the chromo domain: an ancient chromatin module comes of age. , 2001, Gene.

[108]  J. Clayton-Smith,et al.  Angelman syndrome phenotype associated with mutations inMECP2, a gene encoding a methyl CpG binding protein , 2001, Journal of medical genetics.

[109]  R. Jaenisch,et al.  Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice , 2001, Nature Genetics.

[110]  A. Bird,et al.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome , 2001, Nature Genetics.

[111]  T. Casci.  Evo-Devo: A head with no torso , 2000, Nature Reviews Genetics.

[112]  E. Verdin,et al.  BCoR, a novel corepressor involved in BCL-6 repression. , 2000, Genes & development.

[113]  A. Wolffe,et al.  MeCP2 driven transcriptional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery. , 2000, Nucleic acids research.

[114]  D. Higgs,et al.  Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation , 2000, Nature Genetics.

[115]  N. Bérubé,et al.  Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association. , 2000, Human molecular genetics.

[116]  H. Brunner,et al.  A novel ribosomal S6-kinase (RSK4; RPS6KA6) is commonly deleted in patients with complex X-linked mental retardation. , 1999, Genomics.

[117]  A. Pombo,et al.  Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[118]  R. Holliday.  Is there an epigenetic component in long-term memory? , 1999, Journal of theoretical biology.

[119]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[120]  C. Allis,et al.  Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. , 1999, Science.

[121]  P. Sassone-Corsi,et al.  Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[122]  J. Vonesch,et al.  Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators , 1998, The EMBO journal.

[123]  J. Strouboulis,et al.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.

[124]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.

[125]  S. Timsit,et al.  Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein. , 1998, Human molecular genetics.

[126]  S. Cassidy,et al.  Prader‐Willi and Angelman Syndromes: Disorders of Genomic Imprinting , 1998 .

[127]  Steven Finkbeiner,et al.  CREB: A Major Mediator of Neuronal Neurotrophin Responses , 1997, Neuron.

[128]  Ping Fang,et al.  De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome , 1997, Nature Genetics.

[129]  M. Lalande,et al.  UBE3A/E6-AP mutations cause Angelman syndrome , 1996, Nature Genetics.

[130]  F. Jeanmougin,et al.  A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. , 1996, The EMBO journal.

[131]  Raoul C. M. Hennekam,et al.  Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP , 1995, Nature.

[132]  S. Knuutila,et al.  Can Nucleated Erythrocytes Found in Maternal Venous Blood Be Used in the Noninvasive Prenatal Diagnosis of Fetal Chromosome Abnormalities? , 1995, European journal of human genetics : EJHG.

[133]  Michael R. Green,et al.  Nuclear protein CBP is a coactivator for the transcription factor CREB , 1994, Nature.

[134]  Masatoshi Hagiwara,et al.  Phosphorylated CREB binds specifically to the nuclear protein CBP , 1993, Nature.

[135]  D. Feuerbach,et al.  Novel proteins associated with MHC class I antigens in cells expressing the adenovirus protein E3/19K. , 1993, The EMBO journal.

[136]  Y. Barrandon,et al.  A missense mutation in the rod domain of keratin 14 associated with recessive epidermolysis bullosa simplex , 1993, Nature Genetics.

[137]  J. Pearce,et al.  A myotonic syndrome associated with Klinefelter's syndrome. , 1967, Journal of medical genetics.

[138]  A. Sorsby.  Mendelian Inheritance in Man. Catalogs of Autosomal Dominant, Autosomal Recessive, and X-linked Phenotypes , 1967 .